P53 codon 72 polymorphism and risk of cervical carcinoma in Moroccan women

Medical Oncology

Volumn 27, Issue 3, 2010, Pages 861-866

  El Khair, M Meftah ^a,b   Ennaji, M M ^a   El Kebbaj, R ^a,b   Mhand, R Ait ^a   Attaleb, M ^b   El Mzibri, M ^b  

^a HASSAN II UNIVERSITY OF CASABLANCA   (Morocco)

^b CENTRE NATIONAL DE L ENERGIE DES SCIENCES TECHNIQUES NUCLEAIRES   (Morocco)

Author keywords

Cervical cancer; HPV; p53 codon 72 polymorphism

Indexed keywords

AMINO ACID; ARGININE; PROLINE; PROTEIN P53;

ALLELE; ARTICLE; CANCER PAIN; CANCER RISK; CODON; CONTROLLED STUDY; FEMALE; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MOROCCO; ONCOGENE; P53 GENE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; SEXUAL BEHAVIOR; SMOKING; UTERINE CERVIX CARCINOMA; WART VIRUS;

ALLELES; ALPHAPAPILLOMAVIRUS; AMINO ACID SUBSTITUTION; CARCINOMA, SQUAMOUS CELL; CODON; FEMALE; GENES, P53; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MOROCCO; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RISK; TUMOR SUPPRESSOR PROTEIN P53; UTERINE CERVICAL NEOPLASMS;

EID: 77956897714     PISSN: 13570560     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12032-009-9297-6     Document Type: Article

References (39)

1. S Mitra C Misra RK Singh CK Panda S Roychoudhury 2005 Association of specific genotype and haplotype of p53 gene with cervical cancer in India J Clin Pathol 58 26 31 10.1136/jcp.2004.019315 15623478 1:CAS:528:DC%2BD2MXhtFalu78%3D (Pubitemid 40070492)
2. H Zur Hausen 1991 Viruses in human cancers Science 254 1167 1173 10.1126/science.1659743 1659743 1:STN:280:DyaK38%2Fms12lsg%3D%3D
3. N Munoz FX Bosch S de Sanjose, et al. 2003 Epidemiologic classification of human papillomavirus types associated with cervical cancer N Engl J Med 348 518 527 10.1056/NEJMoa021641 12571259 (Pubitemid 36159887)
4. D Saranath Z Khan AT Tandle P Dedhia B Sharma R Contractor, et al. 2002 HPV16/18 prevalence in cervical lesions/cancers and p53 genotypes in cervical cancer patients from India Gynecol Oncol 86 2 157 162 10.1006/gyno.2002.6735 12144822 1:CAS:528:DC%2BD38XlsFKgtLs%3D (Pubitemid 34953498)
5. M Filippova L Parkhurst PJ Duerksen-Hughes 2004 The human papillomavirus 16 E6 protein binds to Fas-associated death domain and protects cells from fastriggered apoptosis J Biol Chem 279 25729 25744 10.1074/jbc.M401172200 15073179 1:CAS:528:DC%2BD2cXksFygtL0%3D (Pubitemid 38756837)
6. WK Baek JW Cho SI Suh MH Suh DH Shin CH Cho, et al. 2000 p53 codon 72 polymorphism and risk of cervical carcinoma in Korean women Korean Med Sci 15 1 65 67 1:CAS:528:DC%2BD3cXhvFektrk%3D
7. M Scheffner BA Werness JM Huibregtse, et al. 1990 The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53 Cell 63 1129 1136 10.1016/0092-8674(90)90409-8 2175676 1:CAS:528: DyaK3MXls12itg%3D%3D
8. BA Werness AJ Levine PM Howley 1990 Association of human papillomavirus types 16 and 18 E6 proteins with p53 Science 248 76 79 10.1126/science.2157286 2157286 1:CAS:528:DyaK3cXktF2ltL0%3D
9. SM Horner RA DeFilippis L Manuelidis, et al. 2004 Repression of the human papillomavirus E6 gene initiates p53-dependent, telomerase-independent senescence and apoptosis in HeLa cervical carcinoma cells J Virol 78 4063 4073 10.1128/JVI.78.8.4063-4073.2004 15047823 1:CAS:528:DC%2BD2cXjtFWltrk%3D (Pubitemid 38437213)
10. T Soussi C Béroud 2001 Assessing TP53 status in human tumours to evaluate clinical outcome Nat Rev Cancer 1 3 233 240 10.1038/35106009 11902578 1:CAS:528:DC%2BD38XlvF2qtrk%3D
11. GJ Matlashewski S Tuck D Pim P Lamb J Schneider LV Crawford 1987 Primary structure polymorphism at amino acid residue 72 of human p53 Mol Cell Biol 7 2 961 963 3547088 1:CAS:528:DyaL2sXhtlarsLo%3D
12. A Storey M Thomas A Kalita C Harwood D Gardiol F Mantovani, et al. 1998 Role of a p53 polymorphism in the development of human papillomavirus-associated cancer Nature 393 6682 229 234 10.1038/30400 9607760 1:CAS:528: DyaK1cXjtlymtLs%3D (Pubitemid 28261713)
13. O Lungu TC Wright Jr S Silverstein 1992 Typing of human papillomaviruses by polymerase chain reaction amplification with L1 consensus primers and RFLP analysis Mol Cell Probes 6 145 152 10.1016/0890-8508(92)90059-7 1355266 1:STN:280:DyaK38zot1Gqug%3D%3D
14. S Andersson E Rylander B Larson S Sigurdardottir I Backlund J Sallstrom, et al. 2003 Types of human papillomavirus revealed in cervical adenocarcinomas after DNA sequencing Oncol Rep 10 175 179 12469166 1:CAS:528:DC%2BD3sXpslKm
15. Ting Y, Manos MM. Detection and typing of genital human papillomaviruses. In: Innis MA, Gelfand DH, Sninsky JJ, White TJ, editors. PCR protocols: a guide to methods and applications. San diego: Academic press; 1990. p. 356-67.
16. HM Bauer Y Ting CE Greer JC Chambers JC Tashiro CL Chimera, et al. 1991 Genital human papillomavirus infection in female university students as determined by a PCR-based method JAMA 256 472 477 10.1001/jama.265.4.472
17. M Amrani K Lalaoui M El Mzibri P Lazo M Alaoui Belabbas 2003 Molecular detection of human papillomavirus in 594 uterine cervix samples from Moroccan women (147 biopsies and 447swabs) J Clin Virol 27 286 295 10.1016/S1386-6532(02) 00227-5 12878093 (Pubitemid 36870905)
18. KW Lo TH Cheung TK Chung VW Wang JS Poon JC Li, et al. 2001 Clinical and prognostic significance of human papillomavirus in a Chinese population of cervical cancers Gynecol Obstet Invest 51 202 207 10.1159/000052925 11306910 1:STN:280:DC%2BD3MzlsFCqtQ%3D%3D (Pubitemid 32304745)
19. J Melnikow J Nuovo AR Willan BK Chan LP Howell 1998 Natural history of cervical squamous intraepithelial lesions: a meta-analysis Obstet Gynecol 92 4 Pt 2 727 735 10.1016/S0029-7844(98)00245-2 9764690 1:STN:280: DyaK1cvjsFOiuw%3D%3D (Pubitemid 28440819)
20. A Koushik A Ghosh E Duarte-Franco P Forest H Voyer G Matlashewski, et al. 2005 Biomarkers of cervical cancer risk (BCCR) Study Team. The p53 codon 72 polymorphism and risk of high-grade cervical intraepithelial neoplasia Cancer Detect Prev 29 4 307 316 10.1016/j.cdp.2005.06.007 16122882 1:CAS:528: DC%2BD2MXhtFyiu7vM (Pubitemid 41267288)
21. N Hamel MJ Black P Ghadirian WD Foulkes 2000 No association between p53 codon 72 polymorphism and risk of squamous cell carcinoma of the head and neck Br J Cancer 82 757 759 10.1054/bjoc.1999.0993 10732740 1:CAS:528: DC%2BD3cXhs1yht78%3D
22. AT Tandle V Sanghvi D Saranath 2001 Determination of p53 genotypes in oral cancer patients from India Br J Cancer 84 739 742 10.1054/bjoc.2000.1674 11259085 1:CAS:528:DC%2BD3MXivVGrtr0%3D (Pubitemid 32275644)
23. SM Brenna ID Silva LC Zeferino JS Pereira EZ Martinez KJ Syrjänen 2004 Prevalence of codon 72 P53 polymorphism in Brazilian women with cervix cancer Genet Mol Biol 27 4 496 499 10.1590/S1415-47572004000400005 1:CAS:528:DC%2BD2MXovVSjtw%3D%3D
24. S Oliveira H Sousa AM Santos D Pinto AL Pinto-Correia D Fontoura, et al. 2008 The p53 R72P polymorphism does not influence cervical cancer development in a Portuguese population: a study in exfoliated cervical cells J Med Virol 80 3 424 429 10.1002/jmv.21103 18205229 1:CAS:528:DC%2BD1cXis1Wjs7s%3D (Pubitemid 351206891)
25. M Thomas A Kalita S Labrecque D Pim L Banks G Matlashewski 1999 Two polymorphic variants of wild-type p53 differ biochemically and biologically Mol Cell Biol 19 1092 1100 9891044 1:CAS:528:DyaK1MXhtVKhsL0%3D
26. NM Wang CH Tsai KT Yeh, et al. 1999 p53 codon 72Arg polymorphism is not a risk factor for carcinogenesis in the Chinese Int J Mol Med 4 249 252 10425273 1:CAS:528:DyaK1MXls1Whsbc%3D
27. MT Wu CL Liu CK Ho, et al. 2004 Genetic polymorphism of p53 and XRCC1 in cervical intraepithelial neoplasm in Taiwanese women J Formos Med Assoc 103 337 343 15216398 1:CAS:528:DC%2BD2cXnvVOqtL4%3D
28. R Klaes R Ridder U Schaefer, et al. 1999 No evidence of p53 allele-specific predisposition in human papillomavirus-associated cervical cancer J Mol Med 77 299 302 10.1007/s001090050353 10023783 1:CAS:528: DyaK1MXhsFSit7g%3D
29. O Humbey F Aubin S Cairey-Remonnay, et al. 2002 TP53 polymorphism at exon 4 in Caucasian women from eastern France: lack of correlation with HPV status and grade of cervical precancerous lesions Eur J Obstet Gynecol Reprod Biol 103 60 64 10.1016/S0301-2115(02)00006-4 12039466 1:CAS:528:DC%2BD38XktVCqtr4%3D (Pubitemid 34606957)
30. AN Rosenthal A Ryan RM Al-Jehani A Storey CA Harwood IJ Jacobs 1998 p53 codon 72 polymorphism and risk of cervical cancer in UK Lancet 352 9131 871 872 10.1016/S0140-6736(98)07357-7 9742979 1:CAS:528:DyaK1cXmtlOlsbY%3D (Pubitemid 28416721)
31. RJ Pegoraro L Rom PA Lanning, et al. 2002 p53 codon 72 polymorphism and human papillomavirus type in relation to cervical cancer in South African women Int J Gynecol Cancer 12 383 388 10.1046/j.1525-1438.2002.01109.x 12144687 1:STN:280:DC%2BD38zps1aktQ%3D%3D (Pubitemid 34839837)
32. SJ Klug R Wilmotte C Santos, et al. 2001 TP53 polymorphism, HPV infection, and risk of cervical cancer Cancer Epidemiol Biomarkers Prev 10 1009 1012 11535556 1:CAS:528:DC%2BD3MXnt1GisLo%3D
33. K Szarka G Veress A Juhasz, et al. 2000 Integration status of virus DNA and p53 codon 72 polymorphism in human papillomavirus type 16 positive cervical cancers Anticancer Res 20 2161 2167 10928171 1:CAS:528:DC%2BD3cXlvFCqs74%3D
34. T Agorastos AF Lambropoulos TC Constantinidis, et al. 2000 p53 codon 72 polymorphism and risk of intra-epithelial and invasive cervical neoplasia in Greek women Eur J Cancer Prev 9 113 118 10.1097/00008469-200004000-00007 10830578 1:STN:280:DC%2BD3cvjtlWgtA%3D%3D (Pubitemid 30337365)
35. A Hildesheim M Schiffman LA Brinton JF Fraumeni Jr R Herrero MC Bratti P Schwartz R Mortel W Barnes M Greenberg L McGowan DR Scott M Martin JE Herrera M Carrington 1998 p53 polymorphism and risk of cervical cancer Nature 396 6711 531 532 10.1038/25040 9859989 1:CAS:528:DyaK1cXotVSqtbg%3D
36. P Bhattacharya C Duttagupta S Sengupta 2002 Proline homozygosity in codon 72 of p53: a risk genotype for human papillomavirus related cervical cancer in Indian women Cancer Lett 188 1-2 207 211 10.1016/S0304-3835(02)00430-5 12406566 1:CAS:528:DC%2BD38Xot1ajsr4%3D (Pubitemid 35292346)
37. P Tenti N Vesentini M Rondo Spaudo R Zappatore P Migliora L Carnevali, et al. 2000 p53 codon 72 polymorphism does not affect the risk of cervical cancer in patients from northern Italy Cancer Epidemiol Biomarkers Prev 9 4 435 438 10794489 1:CAS:528:DC%2BD3cXjt1Cks7k%3D
38. VA Govan S Loubser D Saleh M Hoffman AL Williamson 2007 No relationship observed between human p53 codon-72 genotype and HPV-associated cervical cancer in a population group with a low arginine-72 allele frequency Int J Immunogenet 34 213 217 10.1111/j.1744-313X.2007.00678.x 17504512 1:CAS:528: DC%2BD2sXmt1ers7Y%3D (Pubitemid 46763553)
39. H Sousa AM Santos D Pinto R Medeiros 2007 Is the p53 codon 72 polymorphism a key biomarker for cervical cancer development? A meta-analysis review within European populations Int J Mol Med 20 731 741 17912468 1:CAS:528:DC%2BD2sXhtlOiurfP